The active agent in the nasal spray, 2-bromopalmitate, carries a high risk of interfering with a number of processes, making ...

A nasal spray drug can counteract the cognitive decline and brain damage typical of Alzheimer's disease in animal models.

Bumetanide nasal spray (BNS) has statistical bioequivalence to oral bumetanide, according to a research letter published ...

Researchers at Tel Aviv University have developed an effective, inexpensive, and simple COVID-19 vaccine that can be stored ...

An experimental nasal spray has helped clear toxic protein buildups in the brains of mouse models of Alzheimer's. Its ...

The Abilene Environmental Health Division conducts inspections for food safety compliance. Here are the scores for the week ...

Nasal sprays are key in managing congestion, using saline for moisture, decongestants for swelling, and steroids for deeper ...

Both the nasal and IV forms of bumetanide had a variability in absorption of 27%, suggesting a more stable route of dosing ...

In mice, inhibiting protein S-palmitoylation Counteracted accumulation of harmful proteins in neurons and delayed onset and progression of cognitive decline.

Alzheimer's wonder drugs aren't yet delivering on their promise. American researchers have come up with a brand new idea, a ...

A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione ...

An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...